Darin A Allen

Title: The Innovative Contributions of Darin A. Allen

Introduction

Darin A. Allen is a notable inventor based in Mountain View, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of protease inhibitors. His work focuses on creating novel compounds that have the potential to treat various medical conditions.

Latest Patents

Darin A. Allen holds a patent for his invention titled "(Hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors." This patent describes novel compounds represented by the Formula (I): A-B, which includes prodrug forms and pharmaceutically acceptable salts. The compounds feature a bicyclic heterocyclic ring structure and an aryl or heteroaryl group. Notably, preferred compounds include a benzimidazole or indole nucleus. These compounds serve as inhibitors of serine proteases, Urokinase (uPA), Factor Xa (FXa), and/or Factor VIIa (FVIIa), demonstrating utility as anti-cancer agents and anticoagulants for the treatment or prevention of thromboembolic disorders in mammals. He has 1 patent to his name.

Career Highlights

Darin A. Allen is currently associated with Axys Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work has contributed to advancements in drug development and therapeutic applications.

Collaborations

Throughout his career, Darin has collaborated with notable colleagues, including Jason M. Hataye and Witold N. Hruzewicz. These collaborations have fostered a productive environment for research and development.

Conclusion

Darin A. Allen's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to impact the development of important medical therapies.